1,2-dipalmitoylphosphatidylcholine has been researched along with tacrolimus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McAlister, VC | 1 |
| Cañadas, O; Casals, C; García-Cañero, R; Guerrero, R; Menéndez, M; Orellana, G | 1 |
| Asai, T; Oku, N; Toyota, H | 1 |
3 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and tacrolimus
| Article | Year |
|---|---|
Liposomal tacrolimus: drug migration within blood compartments.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Drug Carriers; Erythrocytes; Injections, Intravenous; Liposomes; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Tacrolimus; Time Factors | 1998 |
Characterization of liposomal tacrolimus in lung surfactant-like phospholipids and evaluation of its immunosuppressive activity.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Cadaverine; Calcium; Calorimetry, Differential Scanning; Crystallization; Diphenylhexatriene; Fluorescence Polarization; Growth Inhibitors; Humans; Immunosuppressive Agents; Interleukin-2; Jurkat Cells; Liposomes; Lymphocyte Activation; Phase Transition; Phosphatidylglycerols; Phospholipids; Pulmonary Surfactant-Associated Protein A; Surface Properties; Tacrolimus | 2004 |
Process optimization by use of design of experiments: Application for liposomalization of FK506.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Drug Compounding; Immunosuppressive Agents; Liposomes; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Tacrolimus | 2017 |